Stoptions.aiStoptions.aiStoptions.aiStoptions.aiStoptions.ai
Powered by Amora Edge
How it worksResultsPricingMeet StoptieCompareBlog
Sign InStart Free Trial
Stoptions.ai
Powered by Amora Edge

Algorithmic scanning across the S&P 500 & Nasdaq 100. Stock & Options trade cards in your inbox by 9:35 AM ET every trading day.

Product
  • How it works
  • The Algorithm
  • Ticker Setups
  • Pricing
  • Morning Brief
  • Results
  • Compare tools
Account
  • Sign In
  • Start Free Trial
  • Give a gift
  • Dashboard
  • Settings
Company
  • About
  • Contact
  • Support
  • Blog
  • Sitemap
Legal
  • Terms of service
  • Privacy policy
  • Risk disclosure
  • Unsubscribe

© 2026 Stoptions.ai · All Rights Reserved

Not financial advice. Algo-generated setups are not personalised investment advice. Options trading involves significant risk of loss — past performance does not guarantee future results.

Chat with Stoptie
Stoptions.ai›Tickers›ARE
Last updated: Fri May 15, 2026 · 9:31 AM ET
↻ Next update: Thu, May 21, 2026 · 9:31 AM ET

AREStock and Options Trade Setup — Alexandria Real Estate EquitiesARE logo

NYSE · REIT (Life Science & Lab Office) · Moderate-liquidity options · Mid-large cap · ~$20B

▲ Bullish setupReal EstateLife Science REITMedium risk↑ Score +4 vs last update
64
Amora Edge Score
64
Top 36% of today's scan
↑ +4 vs last update
Composite of EMA, RSI, RS vs SPY & volume · updated every 72h
60
ARE Win Rate
60%
9 of 15 ARE setups hit target in 2025-2026
Tracks completed Stoptions setups on this ticker since Jan 2026
Why we cover ARE

Alexandria owns the highest-quality, most irreplaceable life-science real estate in the U.S., concentrated in the three biotech ecosystems where venture capital, talent, and academic anchor institutions cluster. Its tenant base skews toward investment-grade pharma and large-cap biotech (Moderna, Eli Lilly, Bristol-Myers, Vertex), providing high credit quality and lease durations averaging 7-8 years. After a deep multiple compression cycle (2022-2025) driven by rising rates and biotech funding drought, the setup has improved as biotech IPOs reopened, venture funding stabilised, and rate expectations softened. Same-store NOI has held positive throughout the cycle, validating the moat. The dividend is well-covered with reasonable AFFO payout ratios, and the development pipeline has been right-sized to reduce capex risk. Options liquidity is moderate; medium-duration directional plays around rate-cut catalysts or biotech sector rotations have worked best.

Score History & Signal Changelog

Preview data

This page is updated every 72 hours with the latest Scan results. Each data point below represents one complete algorithmic snapshot in time.

Score progression across 4 updates
Solid = composite · dashed = components
Signal Changelog
DateUpdateScoreDeltaKey change
May 1#1 Created54—Page created. Biotech funding stabilising; same-store NOI positive.
May 5#2 Update58+4Q1 leasing volume above plan. EMA structure improving.
May 10#3 Update61+3RS rank top decile in REITs. Rate-cut expectations supportive.
May 15#4 Current64+3All four signals Active. Dividend yield + AFFO growth setup forming.

Signal Breakdown

EMA Cross
Active
16/25
Price reclaimed 50-day EMA on May 8; trend structure repairing
RSI Zone
Active
15/25
RSI at 56 — bouncing from oversold readings into neutral momentum
RS vs SPY
Active
17/25
Outperforming SPY +2.6pp as rate-sensitive groups rotate higher
Volume Surge
Active
16/25
1.4x 20-day average on up-days; income-fund accumulation visible

Today's Trade Card

Setup
ARE $110 CALL
Expires Jul 18, 2026
Premium
$2.60
Target
+60% premium
Stop loss
-40% premium
Breakeven
$112.6
Win prob.
56%
Sizing: Risk <= 1% of account
Greeks
Delta
0.45
Theta
-0.04
IVR
26%
IVR class
Low
Trade card available on Pro & Elite
Or Start Free Trial →

Options Profile

Avg IV (30d)
26%
IVR range (52-wk)
14-50%
Put/call ratio
0.78
Avg daily vol.
4.2K contracts
Open interest
62K contracts
Next earnings
Jul 23, 2026 (est.)

Risks & Fundamentals

Every setup carries risk. Here's what could move ARE against you, plus the key stats that frame any position.

Beta
0.9
Market cap
~$20B
Risk level
Medium risk
Next earnings
Jul 23, 2026 (est.)
Key risks to monitor
  • 1.Biotech funding environment stalling out and lab vacancy ticking higher
  • 2.Long-duration interest rates rising materially again, pressuring cap rates
  • 3.Tenant credit events among smaller biotech leaseholders within the portfolio
These are real risks to the long thesis, not a recommendation to short. Stoptions setups are short-dated and stop-protected; size accordingly.

ARE Options Setup — Frequently Asked Questions

Is ARE a good options trade today?+

Alexandria Real Estate Equities (ARE) currently has an Amora Edge Score of 64/100, ranking it top 36% of today's scan. This composite score is built from four sub-signals — EMA cross, RSI zone, relative strength vs SPY, and volume surge — each scored 0–25. The current read is a bullish setup, so the algorithm is positioned bullish (calls / call debit spreads). A score above 65 typically warrants a trade card with stop and target; below that, the setup is on the watchlist but not actionable.

What is ARE's win rate on Stoptions.ai setups?+

ARE's historical win rate on closed Stoptions setups is 60%. Win rate is calculated as the percentage of past ARE trade cards that hit their target price before stopping out. Win rate is most meaningful once a ticker has 10+ closed trades — individual ticker rates can be noisy at smaller samples. Our portfolio-wide win rate across all closed trades is the more stable benchmark.

What strike and expiry does Stoptions.ai suggest for ARE?+

The strike and expiry are shown on the trade card at the top of this page when the setup is active. Stoptions.ai algorithmically selects strikes targeting delta 0.35–0.45 and expirations 30–45 days out, adjusted for current implied volatility rank (IVR). When IVR is high, the system favors call debit spreads to limit vega risk; when IVR is low, single-leg long calls are preferred. The card includes the contract symbol, mid-price entry, stop, and target.

How often is the ARE setup updated?+

Every 72 hours we refresh ARE's Amora Edge Score and trade card. The underlying scan runs daily at 9:00 AM ET (pre-market) and 9:30 AM ET (post-open), so any new signal change is reflected within one trading session. If ARE drops below the entry threshold or the regime shifts (e.g., SPY enters a confirmed bear), the trade card is replaced with a "no setup" notice automatically.

What does the Amora Edge Score measure for ARE?+

The Amora Edge Score is a 0–100 composite of four technical sub-signals applied to ARE: (1) EMA cross — is the 20-day above the 50-day with both trending up? (2) RSI zone — is momentum in the 50–70 sweet spot, or extended/weak? (3) Relative strength vs SPY — is ARE outperforming the market over 20 sessions? (4) Volume surge — is participation above the 20-day average? Each sub-signal contributes 0–25 points. ARE currently scores 64.

How does ARE compare to other REIT (Life Science & Lab Office) setups?+

ARE's sector rank and percentile against other REIT (Life Science & Lab Office) tickers we track is shown on the /tickers index — sortable by Amora Edge Score, win rate, or sector. For direct comparison, see the "Related REIT (Life Science & Lab Office) Options Setups" panel above. When multiple tickers in the same sector are scoring 80+, the algorithm flags the cluster as a sector rotation signal and may upweight position sizing.

Educational content only — not personalized investment advice. Options carry substantial risk.

The Weekly · Free

Get a Friday Recap Including Setups Like ARE.

Every Friday at 4:30 PM ET — Trade of the Week, Signal Movement, Sector Spotlight, Technical Analysis, and more. A 4-minute read. Free.

No spam. One email Friday afternoon. Unsubscribe in one click.

More from Stoptions.ai
← All tickersHow the algorithm worksMorning BriefResultsPricing